Penumbra Inc
NYSE:PEN
| Market Cap (Intraday) | 8.99B |
| Current PE | 212.88 |
| Forward PE | 63.11 |
| 2yr Forward PE | 47.49 |
| 10-Day MA | $247.15 |
| 50-Day MA | $266.27 |
| 200-Day MA | $253.27 |
Penumbra Inc Stock, NYSE:PEN
One Penumbra Place, Alameda, California 94502
United States of America
Phone: +1.510.748.3200
Number of Employees: 4500
Description
Penumbra, Inc. is a thrombectomy company, which designs, develops, manufactures, and markets innovative medical products. It offers neurovascular thrombectomy and embolization and access technologies, neurosurgical tools, Penumbra LANTERN Delivery Microcatheter, and Penumbra Occlusion Device system. The company was founded by Arani Bose and Adam Elsesser on June 21, 2004 and is headquartered in Alameda, CA.